->Nature | More on "GLP-1 drugs treating brain disorders" at BigEarthData.ai | #obesity
R3TA changed the conversation by targeting three metabolic pathways. Now Eli Lilly is taking another step with Brenipatide (LY3537031)an experimental dual GIP/GLP-1 ag*nist being investigated for much more than body composition
R3TA changed the conversation by targeting three metabolic pathways. Now Eli Lilly is taking another step with Brenipatide (LY3537031)an experimental dual GIP/GLP-1 ag*nist being investigated for much more than body composition
(not that odd, respiratory diseases are worsened by obesity, same drug also being studied for asthma!)
GLP1 expressed in lung tissue + GIP antiinflammatory effect should show significant benefits.
(not that odd, respiratory diseases are worsened by obesity, same drug also being studied for asthma!)
GLP1 expressed in lung tissue + GIP antiinflammatory effect should show significant benefits.
Seriously they are just flooding the zone for indications like I've never seen
Seriously they are just flooding the zone for indications like I've never seen
better-experience.blogspot.com/2026/01/aepi...
#WORLDFIRST
allgraph.ro/advanced-sea...
#BRENIPATIDE
headlines-world.com/advanced-sea...
#JOHN #CRIMBER
aepiot.com/advanced-sea...
allgraph.ro
Once-monthly dosing for addiction and psych. Lilly is so confident they jumped straight to P3
2028 will tell us if this actually works www.bigpharmasharma.com/p/the-glp-1-...
Once-monthly dosing for addiction and psych. Lilly is so confident they jumped straight to P3
2028 will tell us if this actually works www.bigpharmasharma.com/p/the-glp-1-...